{
  "id": "clinical#screening_cues_6ba3f5fd",
  "content": "other hallucinogen-induced bipolar disorder (“Bipolar and Related\nDisorders”); other hallucinogen-induced depressive disorder (“De-\npressive Disorders”); and other hallucinogen-induced anxiety disor-\nder (“Anxiety Disorders”). For other hallucinogen intoxication\ndelirium, see the criteria and discussion of delirium in the chapter\n“Neurocognitive Disorders.” These hallucinogen-induced disorders\nare diagnosed instead of other hallucinogen intoxication only when\nthe symptoms are sufficiently severe to warrant independent clinical\nattention.\n252 Substance-Related and Addictive Disorders\nUnspecified Phencyclidine-Related Disorder\n292.9 (F16.99)\nThis category applies to presentations in which symptoms character-\nistic of a phencyclidine-related disorder that cause clinically signifi-\ncant distress or impairment in social, occupational, or other important\nareas of functioning predominate but do not meet the full criteria for\nany specific phencyclidine-related disorder or any of the disorders in\nthe substance-related and addictive disorders diagnostic class.\nUnspecified Hallucinogen-Related Disorder\n292.9 (F16.99)\nThis category applies to presentations in which symptoms character-\nistic of a hallucinogen-related disorder that cause clinically significant\ndistress or impairment in social, occupational, or other important ar-\neas of functioning predominate but do not meet the full criteria for any\nspecific hallucinogen-related disorder or any of the disorders in the\nsubstance-related and addictive disorders diagnostic class.\nInhalant-Related Disorders\nInhalant Use Disorder\nA. A problematic pattern of use of a hydrocarbon-based inhalant",
  "metadata": {
    "source": "DSM-5",
    "url": "https://psychiatry.org/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "stress",
      "screening_cues",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Screening Cues other hallucinogen-induced bipolar disorder (“Bipolar and Related\nDisorders”); other hallucinogen-induced depressive disorder (“De-\npressive Disorders”); and other hallucinogen-induced anxiety disor-\nder (“Anxiety Disorders”). For other hallucinogen intoxication\ndelirium, see the criteria and discussion of delirium in the chapter\n“Neurocognitive Disorders.” These hallucinogen-induced disorders\nare diagnosed instead of other hallucinogen intoxication only when\nthe symptoms are sufficiently severe to warrant independent clinical\nattention.\n252 Substance-Related and Addictive Disorders\nUnspecified Phencyclidine-Related Disorder\n292.9 (F16.99)\nThis category applies to presentations in which symptoms character-\nistic of a phencyclidine-related disorder that cause clinically signifi-\ncant distress or impairment in social, occupational, or other important\nareas of functioning predominate but do not meet the full criteria for\nany specific phencyclidine-related disorder or any of the disorders in\nthe substance-related and addictive disorders diagnostic class.\nUnspecified Hallucinogen-Related Disorder\n292.9 (F16.99)\nThis category applies to presentations in which symptoms character-\nistic of a hallucinogen-related disorder that cause clinically significant\ndistress or impairment in social, occupational, or other important ar-\neas of functioning predominate but do not meet the full criteria for any\nspecific hallucinogen-related disorder or any of the disorders in the\nsubstance-related and addictive disorders diagnostic class.\nInhalant-Related Disorders\nInhalant Use Disorder\nA. A problematic pattern of use of a hydrocarbon-based inhalant Other hallucinogen-induced bipolar disorder (“bipolar and related\ndisorders”); other hallucinogen-induced depressive disorder (“de-\npressive disorders”); and other hallucinogen-induced lo âu disor-\nder (“lo âu disorders”..."
}